The American Journal of Managed Care > October 2019

The American Journal of Managed Care - October 2019

October 07, 2019 – Shirley Cohen-Mekelburg, MD, MS; Russell Rosenblatt, MD, MS; Beth Wallace, MD, MS; Nicole Shen, MD, MS; Brett Fortune, MD, MSc; Akbar K. Waljee, MD, MSc; Sameer Saini, MD, MS; Ellen Scherl, MD; Robert Burakoff, MD; and Mark Unruh, PhD
Thirty-day readmissions related to inflammatory bowel disease are common and associated with longer length of stay and a higher likelihood of having an associated comorbid condition compared with index hospitalizations.
October 11, 2019 – Michael E. Chernew, PhD
October 04, 2019 – Alison Sexton Ward, PhD; Mina Kabiri, PhD; Aylin Yucel, PhD, MSc, MBA, MHSA, PharmD; Alison R. Silverstein, MPH; Emma van Eijndhoven, MS, MA; Charles Bowers, MD; Mark Bensink, PhD, MSc, MEd; and Dana Goldman, PhD
Although currently underutilized, granulocyte colony-stimulating factor prophylaxis as supportive cancer care provides substantial value to society. Aligning utilization with clinical guidelines would increase this value considerably.
October 08, 2019 – James D. Chambers, PhD; Ari D. Panzer, BS; David D. Kim, PhD; Nikoletta M. Margaretos, BA; and Peter J. Neumann, ScD
Health plans restrict orphan drug coverage less often than nonorphan drug coverage. However, the frequency of restrictions varies considerably across plans.
October 09, 2019 – Jonathan L. Vandergrift, MS; and Bradley M. Gray, PhD
Patient-centered practice infrastructure was associated with better care quality only among physicians who scored well on their Maintenance of Certification exam.
October 10, 2019 – Eric Schwartz, MD; Allison Ruff, MD; Michael Kinning, DO; and A. Mark Fendrick, MD
This study evaluates the ease of ordering high- and low-value clinical services in a national sample of electronic health records.
September 24, 2019 – Andrew J. Klink, PhD, MPH; Tammy G. Curtice, PharmD, MBA, MS; Kiran Gupta, PhD, MPharm; Kenneth W. Tuell, RPh, BCGP; A. Richard Szymialis, RPh; Damion Nero, PhD; and Bruce A. Feinberg, DO
This study suggests that lower healthcare resource use and achieving low disease activity are associated with first-line abatacept compared with a first-line tumor necrosis factor-α inhibitor for patients with early rapidly progressive rheumatoid arthritis.
September 25, 2019 – Jangho Yoon, PhD; Lisa P. Oakley, PhD; Jeff Luck, PhD; and S. Marie Harvey, DrPH
Oregon’s Medicaid accountable care organizations led to reductions in preventable hospital admissions, especially unscheduled admissions, among female beneficiaries aged 15 to 44 years.
September 26, 2019 – Charlie Lin, MD; Jansie Prozesky, MBChB; Donald E. Martin, MD; and Verghese T. Cherian, MD
Understanding patients’ expectations, educating them about the role of an anesthesiologist, and involving them in decisions about their medical care can improve patient satisfaction.
September 30, 2019 – Junqing Liu, PhD; Fern McCree, MPH; Doug Kanovsky, BA; Patricia Santora, PhD; Kazi Ahmed, PhD; Chirag Bhatt, MBA; and Sarah H. Scholle, DrPH
Screening and follow-up for unhealthy alcohol use are low among plan members. Use of standardized screening tools, documentation, and care for alcohol misuse need improvement.
October 02, 2019 – En-Ju D. Lin, PhD, MPH; Jennifer L. Hefner, PhD, MPH; Xianlong Zeng, MS; Soheil Moosavinasab, MS; Thomas Huber, PhD, MS; Jennifer Klima, PhD; Chang Liu, PhD; and Simon M. Lin, MD, MBA
Artificial intelligence based on medical claims data outperforms traditional models in stratifying patient risk.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.